Baker Julian's Form 4 filing
Kodiak Sciences Inc. (KOD) · filed Feb 17, 2022
- Accession no.
- 0001209191-22-010914
- Filed
- Feb 17, 2022, 5:33 PM ET
- Trade date
- Feb 15-17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 0 derivative transactions. Open-market purchases total $21.8M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baker JulianCIK 0001087939 | Director, 10% Owner |
| Baker FelixCIK 0001087940 | Director, 10% Owner |
| Baker Bros. Advisors LPCIK 0001263508 | Director, 10% Owner |
| Baker Brothers Life Sciences LPCIK 0001363364 | Director, 10% Owner |
| 667, L.P.CIK 0001551139 | Director, 10% Owner |
| Baker Bros. Advisors (GP) LLCCIK 0001580575 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2022 | Common Stock | PPurchaseAcquired | +441 | $54.16 | +$23,882.36 | 1,166,009 | Indirect | |
| Feb 15, 2022 | Common Stock | PPurchaseAcquired | +5,359 | $54.16 | +$290,216.65 | 14,369,871 | Indirect | |
| Feb 16, 2022 | Common Stock | PPurchaseAcquired | +1,961 | $53.73 | +$105,369.43 | 1,167,970 | Indirect | |
| Feb 16, 2022 | Common Stock | PPurchaseAcquired | +23,804 | $53.73 | +$1,279,048.43 | 14,393,675 | Indirect | |
| Feb 16, 2022 | Common Stock | PPurchaseAcquired | +5,281 | $54.26 | +$286,555.51 | 1,173,251 | Indirect | |
| Feb 16, 2022 | Common Stock | PPurchaseAcquired | +64,119 | $54.26 | +$3,479,199.53 | 14,457,794 | Indirect | |
| Feb 17, 2022 | Common Stock | PPurchaseAcquired | +426 | $53.82 | +$22,926.72 | 1,173,677 | Indirect | |
| Feb 17, 2022 | Common Stock | PPurchaseAcquired | +5,174 | $53.82 | +$278,457.44 | 14,462,968 | Indirect | |
| Feb 17, 2022 | Common Stock | PPurchaseAcquired | +22,403 | $54.57 | +$1,222,614.6 | 1,196,080 | Indirect | |
| Feb 17, 2022 | Common Stock | PPurchaseAcquired | +271,997 | $54.57 | +$14,843,882.68 | 14,734,965 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.